Using a Novel Nanoparticle as An Adjuvant for Inactivated Avian Influenza Vaccine
Journal Title: Journal of Applied Veterinary Sciences - Year 2022, Vol 7, Issue 1
Abstract
The present work evaluated the mesoporous silica nanoparticles (MSNs) as a promising adjuvant in preparation of inactivated avian influenza H9N2 vaccine in chicken. Two inactivated vaccine formulae were prepared by using Montanide™ ISA 71 VG and MSNs as adjuvants. Both vaccine formulae were found to be sterile and safe from local or systemic post-vaccinal reactions. Regarding the vaccine potency, it was found that antibody titer against H9N2 strain was detected in chickens of the group (2) that received the inactivated H9N2 vaccine with MSNs adjuvant and the highest antibody titer (9.6 log2) was detected early at both 2nd and 3rd-week post-vaccination using haemagglutination inhibition test. On the other hand, the antibody titer against the H9N2 virus in chickens of group (1) vaccinated with the inactivated H9N2 vaccine adjuvanted with Montanide ISA 71 was (5.3 log2 and 8.6 log2) at 2nd and 3rd-week post-vaccination respectively and reached its maximum value at 4th-week post-vaccination (9.0 log2). The results of viral shedding in group (1) vaccinated by Montanide ISA 71 H9N2 vaccine showed only virus shedding of 9.3 × 102 EID50 and Ct value of 35.53 2nd day post-challenge (DPC) using Real-time RT-PCR. While in group (2) received MSNs and H9N2 vaccine detected no virus shedding at 2nd DPC, later viral shedding was detected at a rate of 2.4×102 (Ct value of 24,24) and 4.2×102 (Ct value of 26.77) at 4th and 6th DPC respectively in comparison with the control unvaccinated group (3) that had the highest virus shedding value ranged from 3.5×107 (Ct value of 20.34) at 2nd DPC to 3.08×106 (Ct value of 23.92) at 6th DPC. The present work proved the efficacy of silica nanoparticles as a possible adjuvant for inactivated Avian Influenza H9N2 vaccine.
Authors and Affiliations
Amani Mohamed Abbas, Abd El-Moneam M. M. , H. M. El Naggar, S. I. El-Dek, A. A. Farghali, and Mohamed Fekry El Kersh
Keywords
Related Articles
- EP ID EP698583
- DOI https://dx.doi.org/10.21608/javs.2021.100437.1110
- Views 91
- Downloads 0
Causes and Treatment of Feline Dystocia
The objective of the present study was to describe retrospective data, including causes and whether medical and surgical management is suitable for feline dystocia. Data were analysed and described according to original...
Preliminary Studies On The Virus Causing Outbreak Of Duckling Short Beak And Dwarfism Syndrome (Sbds) In Egypt
Many Mule, Muscovy, and Bikini duck flocks in different duck-producing regions in Egypt have shown signs of a new disease designated "short beak and dwarfism syndrome" (SBDS) since 2015. The ducks with SBDS showed strong...
A High Light On Lumpy Skin Disease In Iraq And The Middle East: A Review Article
Lumpy skin disease is an infectious, eruptive disease that affected the different animal species, especially cattle . The causing virus is a member of the poxviridae family with Neethling strain. Transmission of the dise...
A Review on Various Antioxidants Utilized in Bovine Semen Extenders
High-quality cryopreserved bovine semen is vital for successful artificial insemination (AI) program, which is the most inexpensive and the quickest mode of genetic improvement. Cryopreservation of sperm is an effective...
Effects of Marbofloxacin and Ketoprofen on Some Biochemical and Coagulation Parameters in Calves
Marbofloxacin (MBX) is a 3rd generation fluoroquinolone specifically developed for animal health and is an approved antimicrobial agent for the cure of mastitis and respiratory diseases in cattle and swine. Ketoprofen (K...